Back to Scanner
TARS
NASDAQRS 19Score 18Tarsus Pharmaceuticals, Inc.
HealthcareBiotechnology$2.98B
$70.12
-0.2% ($0.11)
-17.7% from 52W High
P/E (TTM)
-45.20
Fwd P/E
—
PEG
—
Analyst Upside
-3.0%
EPS Growth
—
Gross Margin
89.6%
ROE
-19.6%
D/E
0.27
Div Yield
0.0%
Avg Volume
370.8K
Price Chart
Key Levels
SMA 200
$63.34
SMA 50
$68.33
Price
$70.12
52W High
$85.20
Target
$68.00
Setup Radar
0/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst